Evidence map›Paper›PMID 36751702›Full record

ArticleJournal of Zhejiang University. Science. B2023

Yue Qiu, Hongyang Wang, Huaye Pan, Jing Guan, Lei Yan, Mingjie Fan, Hui Zhou, Xuanhao Zhou, Kaiwen Wu, Zexiao Jia and 9 more

Open access · greenAbstract read
In one paragraph

Article in Journal of Zhejiang University. Science. B, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. [Therapeutic potential of NADH: in neurodegenerative diseases characterizde by mitochondrial dysfunction].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2024
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Yue QiuCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Hongyang WangSenior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China.
Huaye PanCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Jing GuanSenior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China.
Lei YanCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Mingjie FanCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Hui ZhouCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Xuanhao ZhouCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Kaiwen WuSenior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China.
Zexiao JiaCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Qianqian ZhuangCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Zhaoying LeiCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Mengyao LiCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Xue DingCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Aifu LinCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Yong FuThe Children's Hospital of Zhejiang University School of Medicine, Hangzhou 310052, China.
Dong ZhangCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Qiuju WangSenior Department of Otolaryngology, Head and Neck Surgery, Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital, Beijing 100853, China. wqcr301@vip.‍sina.com.
Qingfeng YanCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China. qfyan@zju.edu.cn.
Zhejiang University · CNChinese PLA General Hospital · CNChildren's Hospital of Zhejiang University · CNFirst Affiliated Hospital Zhejiang University · CNZhejiang Lab · CN

Funding

the Fundamental Research Funds for the Central Universities 2019QNA6001the National Natural Science Foundation of China 32070584, 81830028, 31771398, 82222016 and 8207040100the Zhejiang Provincial Natural Science Foundation of China LZ19C060001
6 · The paper itself

Abstract

Auditory neuropathy spectrum disorder (ANSD) represents a variety of sensorineural deafness conditions characterized by abnormal inner hair cells and/or auditory nerve function, but with the preservation of outer hair cell function. ANSD represents up to 15% of individuals with hearing impairments. Through mutation screening, bioinformatic analysis and expression studies, we have previously identified several apoptosis-inducing factor (AIF) mitochondria-associated 1 (

Indexed as

Apoptosis Inducing FactorNADApoptosisDimerizationHearing Loss, CentralHumansAIFM1 protein, humanApoptosis Inducing FactorNADApoptosis-inducing factor (AIF) mitochondria-associated 1 (AIFM1) variantsAuditory neuropathy spectrum disorderCaspase-independent apoptosisDimerizationNicotinamide adenine dinucleotide (NADH) treatment

Identifiers

PMID36751702
PMCPMC10260280
OpenAlexW4319460921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.